These data demonstrated that exosomal transfer of THBS1 from oral cancer could polarize macrophages into M1-like TAMs and targeted management of M1-like TAMs shows great potentials for the control of OSCCs, however, there are no ongoing clinical trials. Here, THBS1 is linked to lip and oral cavity carcinoma.